Ablatus Therapeutics: NVM Private Equity (NVM) has invested GBP1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics Limited (Ablatus) alongside existing angel investors.

Ablatus was founded in 2016 as a spin out from the NHS, under the guidance of Health Enterprise East (HEE), to develop and commercialise patented Bimodal Electric Tissue Ablation (BETA) technology. The investment from NVM will support the company through the next stage of commercialisation, including ongoing product development.